查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1418348

生物电子医学市场报告：2030 年趋势、预测与竞争分析

Bioelectric Medicine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

生物电医学的趋势和预测

预计2024年至2030年全球生物电子医疗市场将以4.9%的复合年增长率成长。该市场的主要驱动力是慢性和急性健康问题发病率的增加以及老年人口的增加。全球生物电子医学市场的未来看起来充满希望，在心律不整、疼痛管理、感音性听障、帕金森氏症、震颤、忧郁症、抗治疗性忧郁症以及尿失禁和大便失禁市场都有机会。我是。

生物电医学市场洞察

Lucintel 预测，由于帕金森氏症以及忧郁症和肥胖症等与生活方式相关的疾病发生率不断上升，植入式心臟整流去颤器在预测期内仍将是最大的细分市场。

由于需要心臟心律调节器和植入式心臟整流去颤器来治疗的心律不整频率不断增加，心律不整仍然是这个市场中最大的部分。

由于人们对尖端医疗设备的兴趣日益浓厚，北美在预测期内可能仍将是最大的地区。

常问问题

Q1.市场成长预测如何？

A1. 2024年至2030年，全球生物电子医学市场预计将以4.9%的复合年增长率成长。

Q2.影响市场成长的主要驱动因素有哪些？

A2. 该市场的主要驱动力是慢性和急性健康问题发病率的增加以及老年人口的增加。

Q3.市场的主要细分市场有哪些？

A3. 生物电子医学市场的未来看起来充满希望，在心律不整、疼痛管理、感音性听障、帕金森氏症、震颤、忧郁症、抗治疗性忧郁症、癫痫、尿失禁和大便失禁市场都有机会。我是。

Q4.市场上主要企业有哪些？

A4.主要生物电医疗公司如下。

  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Cochlear
  • Livanova
  • Biotronik
  • Electrocore
  • Sonova
  • Nevro
  • Stimwave

Q5.未来最大的细分市场是什么？

A5.Lucintel 预测，由于帕金森氏症以及忧郁症和肥胖等与生活方式选择相关的疾病发生率不断上升，植入式心臟整流去颤器在预测期内仍将是最大的细分市场。

Q6. 未来五年预计哪个地区将成为最大的市场？

A6. 由于人们对尖端医疗设备的兴趣日益浓厚，北美在预测期内仍将是最大的地区。

Q7. 可以客製化报告吗？

A7. 是的，Lucintel 提供 10% 的客製化服务，无需额外费用。

目录

第一章执行摘要

第二章全球生物电子医疗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球生物电子医疗市场趋势（2018-2023）与预测（2024-2030）
  • 全球生物电子医学市场（按产品）
    • 植入式心臟整流去颤器
    • 心臟心律调节器
    • 人工电子耳
    • 脊髓刺激设备
    • 深层脑部刺激器
    • 经皮神经刺激设备
    • 荐骨神经刺激器
    • 迷走神经刺激设备
    • 其他的
  • 按类型分類的全球生物电子医学市场
    • 植入式电气设备
    • 非侵入性电气设备
  • 全球生物电子医学市场按应用
    • 心律不整
    • 疼痛管理
    • 感音性听障
    • 帕金森氏症
    • 震颤
    • 忧郁症
    • 抗治疗性忧郁症
    • 尿失禁和大便失禁
    • 其他的
  • 按最终用途分類的全球生物电子医学市场
    • 医院
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球生物电子医疗市场区域分布
  • 北美生物电医疗市场
  • 欧洲生物电子医疗市场
  • 亚太地区生物电子医疗市场
  • 其他地区生物电医疗市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球生物电子医学市场成长机会（按产品）
    • 按类型分類的全球生物电子医学市场成长机会
    • 全球生物电子医学市场成长机会（按应用）
    • 按最终用途分類的全球生物电子医学市场成长机会
    • 全球生物电子医学市场按地区成长机会
  • 全球生物电医学市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球生物电子医学市场的产能
    • 全球生物电子医疗市场的併购和合资企业
    • 认证和许可

第七章主要企业概况

  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Cochlear
  • LivaNova
  • Biotronik
  • electroCore
  • Sonova
  • Nevro
  • Stimwave
简介目录

Bioelectric Medicine Trends and Forecast

The future of the global bioelectric medicine market looks promising with opportunities in the arrhythmia, pain management, sensorineural hearing loss, parkinson's disease, tremor, depression, treatment-resistant depressionepilepsy, and urinary and fecal incontinence markets. The global bioelectric medicine market is expected to grow with a CAGR of 4.9% from 2024 to 2030. The major drivers for this market are rising occurrence of both chronic and acute health issues and expanding demographic of elderly individuals highlights.

A more than 150-page report is developed to help in your business decisions.

Bioelectric Medicine by Segment

The study includes a forecast for the global bioelectric medicine by product, type, application, end use, and region.

Bioelectric Medicine Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Implantable Cardioverter Defibrillators
  • Cardiac Pacemakers
  • Cochlear Implants
  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Transcutaneous Electrical Nerve Stimulators
  • Sacral Nerve Stimulators
  • Vagus Nerve Stimulators
  • Others

Bioelectric Medicine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Implantable Electroceutical Devices
  • Non-Invasive Electroceutical Devices

Bioelectric Medicine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Arrhythmia
  • Pain Management
  • Sensorineural Hearing Loss
  • Parkinson'S Disease
  • Tremor
  • Depression
  • Treatment-Resistant Depressionepilepsy
  • Urinary And Fecal Incontinence
  • Others

Bioelectric Medicine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Others

Bioelectric Medicine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Bioelectric Medicine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bioelectric medicine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bioelectric medicine companies profiled in this report include-

  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Cochlear
  • Livanova
  • Biotronik
  • Electrocore
  • Sonova
  • Nevro
  • Stimwave

Bioelectric Medicine Market Insights

Lucintel forecasts that implantable cardioverter defibrillators will remain the largest segment over the forecast period due to rising rates of parkinson's disease and diseases linked to lifestyle choices, such depression and obesity.

Within this market, arrhythmia will remain the largest segment due to increasing frequency of arrhythmias requiring the use of cardiac pacemakers and implanted cardioverter-defibrillators for therapy.

North America will remain the largest region over the forecast period due to increasing interest in cutting-edge medical devices.

Features of the Global Bioelectric Medicine Market

Market Size Estimates: Bioelectric medicine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Bioelectric medicine market size by various segments, such as by product, type, application, end use, and region in terms of value ($B).

Regional Analysis: Bioelectric medicine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, type, application, end use, and regions for the bioelectric medicine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bioelectric medicine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for bioelectric medicine market?

Answer: The global bioelectric medicine market is expected to grow with a CAGR of 4.9% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the bioelectric medicine market?

Answer: The major drivers for this market are rising occurrence of both chronic and acute health issues and expanding demographic of elderly individuals highlights.

Q3. What are the major segments for bioelectric medicine market?

Answer: The future of the bioelectric medicine market looks promising with opportunities in the arrhythmia, pain management, sensorineural hearing loss, parkinson's disease, tremor, depression, treatment-resistant depressionepilepsy, and urinary and fecal incontinence markets.

Q4. Who are the key bioelectric medicine market companies?

Answer: Some of the key bioelectric medicine companies are as follows.

  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Cochlear
  • Livanova
  • Biotronik
  • Electrocore
  • Sonova
  • Nevro
  • Stimwave

Q5. Which bioelectric medicine market segment will be the largest in future?

Answer: Lucintel forecasts that implantable cardioverter defibrillators will remain the largest segment over the forecast period due to rising rates of Parkinson's disease and diseases linked to lifestyle choices, such depression and obesity.

Q6. In bioelectric medicine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing interest in cutting-edge medical devices.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the bioelectric medicine market by product (implantable cardioverter defibrillators, cardiac pacemakers, cochlear implants, spinal cord stimulators, deep brain stimulators, transcutaneous electrical nerve stimulators, sacral nerve stimulators, vagus nerve stimulators, and others), type (implantable electroceutical devices and non-invasive electroceutical devices), application (arrhythmia, pain management, sensorineural hearing loss, parkinson's disease, tremor, depression, treatment-resistant depressionepilepsy, urinary and fecal incontinence, and others), end use (hospitals and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Bioelectric Medicine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Bioelectric Medicine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Bioelectric Medicine Market by Product
    • 3.3.1: Implantable Cardioverter Defibrillators
    • 3.3.2: Cardiac Pacemakers
    • 3.3.3: Cochlear Implants
    • 3.3.4: Spinal Cord Stimulators
    • 3.3.5: Deep Brain Stimulators
    • 3.3.6: Transcutaneous Electrical Nerve Stimulators
    • 3.3.7: Sacral Nerve Stimulators
    • 3.3.8: Vagus Nerve Stimulators
    • 3.3.9: Others
  • 3.4: Global Bioelectric Medicine Market by Type
    • 3.4.1: Implantable Electroceutical Devices
    • 3.4.2: Non-invasive Electroceutical Devices
  • 3.5: Global Bioelectric Medicine Market by Application
    • 3.5.1: Arrhythmia
    • 3.5.2: Pain Management
    • 3.5.3: Sensorineural Hearing Loss
    • 3.5.4: Parkinson's Disease
    • 3.5.5: Tremor
    • 3.5.6: Depression
    • 3.5.7: Treatment-resistant DepressionEpilepsy
    • 3.5.8: Urinary and Fecal Incontinence
    • 3.5.9: Others
  • 3.6: Global Bioelectric Medicine Market by End Use
    • 3.6.1: Hospitals
    • 3.6.2: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Bioelectric Medicine Market by Region
  • 4.2: North American Bioelectric Medicine Market
    • 4.2.2: North American Bioelectric Medicine Market by Application: Arrhythmia, Pain Management, Sensorineural Hearing Loss, Parkinson's Disease, Tremor, Depression, Treatment-resistant DepressionEpilepsy, Urinary and Fecal Incontinence, and Others
  • 4.3: European Bioelectric Medicine Market
    • 4.3.1: European Bioelectric Medicine Market by Product: Implantable Cardioverter Defibrillators, Cardiac Pacemakers, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Transcutaneous Electrical Nerve Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Others
    • 4.3.2: European Bioelectric Medicine Market by Application: Arrhythmia, Pain Management, Sensorineural Hearing Loss, Parkinson's Disease, Tremor, Depression, Treatment-resistant DepressionEpilepsy, Urinary and Fecal Incontinence, and Others
  • 4.4: APAC Bioelectric Medicine Market
    • 4.4.1: APAC Bioelectric Medicine Market by Product: Implantable Cardioverter Defibrillators, Cardiac Pacemakers, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Transcutaneous Electrical Nerve Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Others
    • 4.4.2: APAC Bioelectric Medicine Market by Application: Arrhythmia, Pain Management, Sensorineural Hearing Loss, Parkinson's Disease, Tremor, Depression, Treatment-resistant DepressionEpilepsy, Urinary and Fecal Incontinence, and Others
  • 4.5: ROW Bioelectric Medicine Market
    • 4.5.1: ROW Bioelectric Medicine Market by Product: Implantable Cardioverter Defibrillators, Cardiac Pacemakers, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Transcutaneous Electrical Nerve Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Others
    • 4.5.2: ROW Bioelectric Medicine Market by Application: Arrhythmia, Pain Management, Sensorineural Hearing Loss, Parkinson's Disease, Tremor, Depression, Treatment-resistant DepressionEpilepsy, Urinary and Fecal Incontinence, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Bioelectric Medicine Market by Product
    • 6.1.2: Growth Opportunities for the Global Bioelectric Medicine Market by Type
    • 6.1.3: Growth Opportunities for the Global Bioelectric Medicine Market by Application
    • 6.1.4: Growth Opportunities for the Global Bioelectric Medicine Market by End Use
    • 6.1.5: Growth Opportunities for the Global Bioelectric Medicine Market by Region
  • 6.2: Emerging Trends in the Global Bioelectric Medicine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Bioelectric Medicine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bioelectric Medicine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Medtronic
  • 7.2: Abbott
  • 7.3: Boston Scientific Corporation
  • 7.4: Cochlear
  • 7.5: LivaNova
  • 7.6: Biotronik
  • 7.7: electroCore
  • 7.8: Sonova
  • 7.9: Nevro
  • 7.10: Stimwave